We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.78%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.84B
AUM Growth
-$535M
Cap. Flow
-$207M
Cap. Flow %
-3.54%
Top 10 Hldgs %
25.28%
Holding
175
New
17
Increased
89
Reduced
33
Closed
14

Top Buys

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$43.8M
2
NXT icon
Nextpower Inc
NXT
+$38.9M
3
NTNX icon
Nutanix
NTNX
+$36.8M
4
PWR icon
Quanta Services
PWR
+$33.4M
5
EVH icon
Evolent Health
EVH
+$28M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$165M
2
COUR icon
Coursera
COUR
+$63.3M
3
SPT icon
Sprout Social
SPT
+$57.1M
4
DLO icon
dLocal
DLO
+$49.4M
5
MDB icon
MongoDB
MDB
+$42.1M

Sector Composition

Rank Sector Weight
1 Healthcare 37.83%
2 Technology 24.9%
3 Industrials 17.52%
4 Consumer Discretionary 8.37%
5 Communication Services 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
151
Home Depot
HD
$332B
$1.82M 0.03%
+5,274
New +$1.8M
NOW icon
152
ServiceNow
NOW
$114B
$1.67M 0.03%
10,600
+4,000
+61% +$587K
RSG icon
153
Republic Services
RSG
$65B
$1.58M 0.03%
+8,136
New +$1.54M
UNP icon
154
Union Pacific
UNP
$172B
$1.5M 0.03%
6,637
+2,486
+60% +$583K
PRVA icon
155
Privia Health
PRVA
$3.01B
$1.32M 0.02%
76,207
-923,793
-92% -$16.4M
TSBX
156
DELISTED
Turnstone Biologics
TSBX
$1.2M 0.02%
458,317
– –
RAPP
157
Rapport Therapeutics
RAPP
$2.05B
$1.16M 0.02%
+50,000
New +$1.16M
MU icon
158
Micron Technology
MU
$988B
$1.12M 0.02%
+8,513
New +$1.07M
LLY icon
159
Eli Lilly
LLY
$1.03T
$1.07M 0.02%
1,182
+308
+35% +$246K
FIVN icon
160
CALL
FIVE9
FIVN
$2.12B
$2.24K ﹤0.01%
32,000
– –
JBIO
161
Jade Biosciences
JBIO
$1.22B
– –
-12,729
Closed -$13.2M
COUR icon
162
Coursera
COUR
$1.51B
– –
-4,515,809
Closed -$63.3M
DLO icon
163
dLocal
DLO
$4.41B
– –
-3,362,993
Closed -$49.4M
EQIX icon
164
Equinix
EQIX
$103B
– –
-12,357
Closed -$10.2M
INTA icon
165
Intapp
INTA
$2.47B
– –
-67,446
Closed -$2.31M
MASS icon
166
908 Devices
MASS
$313M
– –
-1,430,995
Closed -$10.8M
RARE icon
167
Ultragenyx Pharmaceutical
RARE
$2.56B
– –
-359,000
Closed -$16.8M
RCUS icon
168
Arcus Biosciences
RCUS
$3.55B
– –
-240,000
Closed -$4.53M
SPT icon
169
Sprout Social
SPT
$509M
– –
-956,464
Closed -$57.1M
TRML
170
DELISTED
Tourmaline Bio
TRML
– –
-320,916
Closed -$7.35M
WM icon
171
Waste Management
WM
$90.9B
– –
-7,982
Closed -$1.7M
SWAV
172
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-507,418
Closed -$165M
ALPN
173
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-408,542
Closed -$16.2M
MRNS
174
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-2,346,526
Closed -$21.2M
3 4 5 6
7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Eventide Asset Management held 175 positions worth $5.84B, down 8.4% from $6.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $207M in Q2 2024, closing 14 positions and reducing 33 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Nextpower Inc worth $36.6M.

  • Eventide Asset Management's largest Q2 2024 buy was Nextpower Inc: 781,302 shares worth $36.6M.
  • Eventide Asset Management added most to Axsome Therapeutics in Q2 2024, an estimated $43.8M increase.
  • Eventide Asset Management's biggest Q2 2024 reduction was MongoDB, cutting an estimated $42.1M.
  • Eventide Asset Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.84B portfolio in Q2 2024.
  • Eventide Asset Management opened 17 new positions and closed 14 in Q2 2024.
  • Eventide Asset Management's portfolio value fell 8.4% quarter-over-quarter to $5.84B.

Based on Eventide Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.